Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) refers to the accumulation of lipid laden
vacuoles in hepatocytes, occurring in the context of visceral adiposity, insulin resistance and …

Recent advances in the genetics of metabolic dysfunction-associated steatotic liver disease
(MASLD) are gradually revealing the mechanisms underlying the heterogeneity of the …

Background & Aims Metabolic dysfunction-associated steatotic liver disease (MASLD;
formerly NAFLD) is the fastest growing cause of hepatocellular carcinoma (HCC) worldwide …

Abstract Background and Aims Nonalcoholic fatty liver disease (NAFLD) is a complex
disease, resulting from the interplay between environmental determinants and genetic …

Abstract Background & Aims Non-alcoholic fatty liver disease (NAFLD) is a complex trait with
an estimated prevalence of 25% globally. We aimed to identify the genetic variant …

Background It is unclear whether the patatin‐like phospholipase domain‐containing protein
3 (PNPLA3) rs738409 C‐to‐G single nucleotide polymorphism, resulting in the substitution …

Background & Aims Metabolic dysfunction associated steatotic liver disease (MASLD) has a
strong genetic component. The aim of this study was to examine noninvasively the …

Background The increasing prevalence of metabolic dysfunction‐associated steatotic liver
disease (MASLD), formerly known as non‐alcoholic fatty liver disease (NAFLD), parallels …

Obesity and associated morbidities, metabolic associated fatty liver disease (MAFLD)
included, constitute some of the largest public health threats worldwide. Body composition …

The growing NAFLD pandemic urges clinicians to seek alternatives for screening, early
diagnosis, and follow-up, especially for those with contraindications for liver biopsy. New …